Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $17.51 billion. The enterprise value is $16.27 billion.
| Market Cap | 17.51B |
| Enterprise Value | 16.27B |
Important Dates
The last earnings date was Thursday, October 29, 2026, after market close.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 244.01 million shares outstanding. The number of shares has decreased by -7.47% in one year.
| Current Share Class | 244.01M |
| Shares Outstanding | 244.01M |
| Shares Change (YoY) | -7.47% |
| Shares Change (QoQ) | -1.51% |
| Owned by Insiders (%) | 2.67% |
| Owned by Institutions (%) | 97.15% |
| Float | 209.83M |
Valuation Ratios
The trailing PE ratio is 21.43 and the forward PE ratio is 17.95. Exelixis's PEG ratio is 1.58.
| PE Ratio | 21.43 |
| Forward PE | 17.95 |
| PS Ratio | 7.01 |
| Forward PS | 6.25 |
| PB Ratio | 9.57 |
| P/TBV Ratio | 9.89 |
| P/FCF Ratio | 15.08 |
| P/OCF Ratio | 14.92 |
| PEG Ratio | 1.58 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.76, with an EV/FCF ratio of 14.01.
| EV / Earnings | 18.38 |
| EV / Sales | 6.52 |
| EV / EBITDA | 15.76 |
| EV / EBIT | 16.20 |
| EV / FCF | 14.01 |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.21 |
| Quick Ratio | 2.99 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 44.32% and return on invested capital (ROIC) is 73.33%.
| Return on Equity (ROE) | 44.32% |
| Return on Assets (ROA) | 23.52% |
| Return on Invested Capital (ROIC) | 73.33% |
| Return on Capital Employed (ROCE) | 47.78% |
| Weighted Average Cost of Capital (WACC) | 6.49% |
| Revenue Per Employee | $2.32M |
| Profits Per Employee | $821,857 |
| Employee Count | 1,077 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 3.26 |
Taxes
In the past 12 months, Exelixis has paid $180.70 million in taxes.
| Income Tax | 180.70M |
| Effective Tax Rate | 16.95% |
Stock Price Statistics
The stock price has increased by +75.79% in the last 52 weeks. The beta is 0.42, so Exelixis's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +75.79% |
| 50-Day Moving Average | 61.27 |
| 200-Day Moving Average | 51.71 |
| Relative Strength Index (RSI) | 70.50 |
| Average Volume (20 Days) | 2,822,424 |
Short Selling Information
The latest short interest is 27.31 million, so 11.19% of the outstanding shares have been sold short.
| Short Interest | 27.31M |
| Short Previous Month | 28.18M |
| Short % of Shares Out | 11.19% |
| Short % of Float | 13.02% |
| Short Ratio (days to cover) | 11.69 |
Income Statement
In the last 12 months, Exelixis had revenue of $2.50 billion and earned $885.14 million in profits. Earnings per share was $3.35.
| Revenue | 2.50B |
| Gross Profit | 2.40B |
| Operating Income | 1.00B |
| Pretax Income | 1.07B |
| Net Income | 885.14M |
| EBITDA | 1.03B |
| EBIT | 1.00B |
| Earnings Per Share (EPS) | $3.35 |
Balance Sheet
The company has $892.02 million in cash and $162.20 million in debt, with a net cash position of $1.24 billion or $5.07 per share.
| Cash & Cash Equivalents | 892.02M |
| Total Debt | 162.20M |
| Net Cash | 1.24B |
| Net Cash Per Share | $5.07 |
| Equity (Book Value) | 1.83B |
| Book Value Per Share | 7.49 |
| Working Capital | 909.75M |
Cash Flow
In the last 12 months, operating cash flow was $1.17 billion and capital expenditures -$11.97 million, giving a free cash flow of $1.16 billion.
| Operating Cash Flow | 1.17B |
| Capital Expenditures | -11.97M |
| Depreciation & Amortization | 27.81M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.16B |
| FCF Per Share | $4.76 |
Margins
Gross margin is 96.26%, with operating and profit margins of 40.21% and 35.45%.
| Gross Margin | 96.26% |
| Operating Margin | 40.21% |
| Pretax Margin | 42.69% |
| Profit Margin | 35.45% |
| EBITDA Margin | 41.33% |
| EBIT Margin | 40.21% |
| FCF Margin | 46.50% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.47% |
| Shareholder Yield | 7.47% |
| Earnings Yield | 4.67% |
| FCF Yield | 6.63% |
Analyst Forecast
The average price target for Exelixis is $61.57, which is -14.18% lower than the current price. The consensus rating is "Buy".
| Price Target | $61.57 |
| Price Target Difference | -14.18% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 12.62% |
| EPS Growth Forecast (3Y) | 17.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 13.36 and a Piotroski F-Score of 5.
| Altman Z-Score | 13.36 |
| Piotroski F-Score | 5 |